{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:51:48Z","timestamp":1773237108449,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.clinthera.2008.12.015","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T05:00:35Z","timestamp":1232686835000},"page":"2366-2377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: Post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults"],"prefix":"10.1016","volume":"30","author":[{"given":"Alan","family":"Kivitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fairfax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Sheldon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinfang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold R.","family":"Gammaitoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Errol M.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2008.12.015_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00002512-200522020-00005","article-title":"Disease-modifying therapies for osteoarthritis: Current status","volume":"22","author":"Fajardo","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.clinthera.2008.12.015_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0033-8389(03)00161-1","article-title":"An update on the pathogenesis and epidemiology of osteoarthritis","volume":"42","author":"Felson","year":"2004","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.clinthera.2008.12.015_bib3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","article-title":"Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States","volume":"41","author":"Lawrence","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2008.12.015_bib4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0950-3579(97)80011-8","article-title":"Economics of osteoarthritis: A global perspective","volume":"11","author":"March","year":"1997","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1016\/j.clinthera.2008.12.015_bib5","first-page":"646","article-title":"Burden of major musculoskeletal conditions","volume":"81","author":"Woolf","year":"2003","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.clinthera.2008.12.015_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2105\/AJPH.84.3.351","article-title":"The effects of specific medical conditions on the functional limitations of elders in the Framingham Study","volume":"84","author":"Guccione","year":"1994","journal-title":"Am J Pub Health"},{"key":"10.1016\/j.clinthera.2008.12.015_bib7","first-page":"699","article-title":"Direct and indirect costs of osteoarthritis of the knee","volume":"22","author":"Leardini","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clinthera.2008.12.015_bib8","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1185\/030079904X2754","article-title":"Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis","volume":"20","author":"Galer","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2008.12.015_bib9","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/sj.bjp.0704428","article-title":"Analgesic activity of a novel use-dependent sodium channel blocker, crobenetine, in monoarthritic rats","volume":"134","author":"Laird","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinthera.2008.12.015_bib10","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","article-title":"Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 Update","volume":"43","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2008.12.015_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00003495-200363001-00006","article-title":"A randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee","volume":"63","author":"Bianchi","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2008.12.015_bib12","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","article-title":"EULAR Recommendations 2003: An evidence based approach to the management of knee osteoarthritis: Report of aTask Force ofthe Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)","volume":"62","author":"Jordan","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2008.12.015_bib13","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/archinte.164.12.1299","article-title":"Treatment options in knee osteoarthritis: The patient's perspective","volume":"164","author":"Fraenkel","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2008.12.015_bib14","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0140-6736(04)17514-4","article-title":"Risk of cardiovascular events and rofecoxib: Cumulative meta-analysis","volume":"364","author":"J\u00fcni","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2008.12.015_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/jama.293.3.366","article-title":"Arthritis medicines and cardiovascular events-\u201chouse of coxibs\u201d","volume":"293","author":"Topol","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2008.12.015_ceotherref1","unstructured":"US Food and Drug Administration. FDA Public Health Advisory: FDA announces important changes and additional warnings for Cox-2 selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs)."},{"key":"10.1016\/j.clinthera.2008.12.015_bib17","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archinte.165.9.978","article-title":"Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: A population-based case-control study","volume":"165","author":"Johnsen","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2008.12.015_bib18","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of non-steroidal antiinflammatory drugs [published correction appears in N Engl J Med. 1999;341:548]","volume":"340","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.12.015_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0091270002239817","article-title":"Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: A review of the literature","volume":"43","author":"Gammaitoni","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2008.12.015_bib20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.joca.2003.10.007","article-title":"Lidocaine patch 5% improves pain, stiffness, and physical function in osteoarthritis pain patients. A prospective, multicenter, open-label effectiveness trial","volume":"12","author":"Burch","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.clinthera.2008.12.015_ceotherref2","unstructured":"World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects [WMA Web site]."},{"key":"10.1016\/j.clinthera.2008.12.015_ceotherref3","unstructured":"Guidance for Industry. E6 Good Clinical Practice: Consolidated Guidance."},{"key":"10.1016\/j.clinthera.2008.12.015_bib23","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2008.12.015_bib24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch General Psychiatry"},{"key":"10.1016\/j.clinthera.2008.12.015_bib25","series-title":"Pain: Clinical Manual","first-page":"61","article-title":"Brief Pain Inventory","year":"1999"},{"key":"10.1016\/j.clinthera.2008.12.015_bib26","first-page":"779","article-title":"The algofunctional indices for hip and knee osteoarthritis","volume":"24","author":"Lecluesne","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2008.12.015_bib27","first-page":"1833","article-title":"Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee","volume":"15","author":"Bellamy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2008.12.015_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0304-3959(83)90143-4","article-title":"Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases","volume":"17","author":"Daut","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2008.12.015_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/pst.267","article-title":"Handling drop-out in longitudinal clinical trials: A comparison of the LOCF and MMRM approaches","volume":"7","author":"Lane","year":"2008","journal-title":"Pharm Stat"},{"key":"10.1016\/j.clinthera.2008.12.015_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1081\/BIP-100104194","article-title":"Accounting for dropout bias using mixed-effects models","volume":"11","author":"Mallinckrodt","year":"2001","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.clinthera.2008.12.015_bib31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/biostatistics\/kxh001","article-title":"Analyzing incomplete longitudinal clinical trial data","volume":"5","author":"Molenberghs","year":"2004","journal-title":"Biostatistics"},{"key":"10.1016\/j.clinthera.2008.12.015_bib32","unstructured":"Xiang Q, Barlas S. A pattern mixture model with least square splines in the analysis of longitudinal data with non-ignorable dropout: RCT data from lidoderm patch 5% for pain from osteoarthritis of the knee. Presented at: Program and Abstracts of the International Biometric Society Eastern North American Region Spring Meeting; March 11\u201314, 2007; Atlanta, Ga."},{"key":"10.1016\/j.clinthera.2008.12.015_bib33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1037\/1082-989X.2.1.64","article-title":"Application of randomeffects pattern-mixture models for missing data in longitudinal studies","volume":"2","author":"Hedeker","year":"1997","journal-title":"Psychol Methods"},{"key":"10.1016\/j.clinthera.2008.12.015_bib34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/01621459.1993.10594302","article-title":"Pattern-mixture models for multivariate incomplete data","volume":"88","author":"Little","year":"1993","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.clinthera.2008.12.015_bib35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/(SICI)1097-0258(19970215)16:3<239::AID-SIM483>3.0.CO;2-X","article-title":"Mixture models for the joint distribution of repeated measures and event times","volume":"16","author":"Hogan","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.clinthera.2008.12.015_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/ard.50.1.8","article-title":"Study of 500 patients with limb joint osteoarthritis. I. Analysis by age, sex, and distribution of symptomatic joint sites","volume":"50","author":"Cushnaghan","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2008.12.015_bib37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/joca.2001.0509","article-title":"Characterization of infiltrating T cells and Th1\/Th2-type cytokines in the synovium of patients with osteoarthritis","volume":"10","author":"Ishii","year":"2002","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.clinthera.2008.12.015_bib38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1079-2104(99)70105-8","article-title":"Association between arthroscopic diagnosis of temporo-mandibular joint osteoarthritis and synovial fluid nitric oxide levels","volume":"88","author":"Takahashi","year":"1999","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.clinthera.2008.12.015_bib39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00000539-200101000-00025","article-title":"The effects of lidocaine on nitric oxide production from an activated murine macrophage cell line","volume":"92","author":"Shiga","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1016\/j.clinthera.2008.12.015_bib40","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1067\/mai.2002.122155","article-title":"Inhibitory effect of lidocaine on T cells from patients with allergic asthma","volume":"109","author":"Tanaka","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2008.12.015_bib41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pain.2004.01.033","article-title":"Decreasing sympathetic sprouting in pathologic sensory ganglia: A new mechanism for treating neuropathic pain using lidocaine","volume":"109","author":"Zhang","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2008.12.015_bib42","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJMp048286","article-title":"Failing the public health\u2014rofecoxib, Merck, and the FDA","volume":"351","author":"Topol","year":"2004","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2008.12.015_bib43","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1185\/030079904X12951","article-title":"Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: Results of a pilot 2-week, open-label study using the Neuropathic Pain Scale","volume":"20","author":"Gammaitoni","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2008.12.015_bib44","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.4065\/74.11.1095","article-title":"Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: A randomized controlled trial","volume":"74","author":"Bensen","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinthera.2008.12.015_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/030097401750065265","article-title":"Celecoxib versus diclofenac in the management of osteoarthritis of the knee","volume":"30","author":"McKenna","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clinthera.2008.12.015_bib46","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0149-2918(01)80004-7","article-title":"Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee","volume":"23","author":"Williams","year":"2001","journal-title":"Clin Ther"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808004505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808004505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:01:40Z","timestamp":1762246900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291808004505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0149291808004505"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.12.015","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: Post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Excerpta Medica Inc. All rights reserved. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}